Sees FY25 Adjusted EBITDA $310M-$340M. Sees FY25 R&D Expenses $305M-$335M; and SG&A Expenses $655M-$685M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALKS: